"cancer biomarker" trang 11 - tải miễn phí từ tailieunhanh
Breast ductal lavage for biomarker assessment in high risk women: Rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

Breast ductal lavage for biomarker assessment in high risk women: Rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo
10    58    1
PDXGEM: Patient-derived tumor xenograftbased gene expression model for predicting clinical response to anticancer therapy in cancer patients

PDXGEM: Patient-derived tumor xenograftbased gene expression model for predicting clinical response to anticancer therapy in cancer patients
21    59    1
Adaptively capturing the heterogeneity of expression for cancer biomarker identification

Adaptively capturing the heterogeneity of expression for cancer biomarker identification
12    54    1
Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data

Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data
14    46    1
Identifcation of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA‑Seq

Identifcation of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA‑Seq
17    42    1
ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors

ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors
14    21    1
Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer

Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
7    35    1
A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers
11    18    1
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: Implications on prognostic immunological biomarker and vaccine design

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: Implications on prognostic immunological biomarker and vaccine design
9    54    1
How are we evaluating the costeffectiveness of companion biomarkers for targeted cancer therapies? A systematic review

How are we evaluating the costeffectiveness of companion biomarkers for targeted cancer therapies? A systematic review
21    35    1
A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma

A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma
15    51    1
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
13    18    1
Clinical and economic impact of ‘ROS1- testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain

Clinical and economic impact of ‘ROS1- testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain
13    27    1
Re-wiring and gene expression changes of AC025034.1 and ATP2B1 play complex roles in early-to-late breast cancer progression

Re-wiring and gene expression changes of AC025034.1 and ATP2B1 play complex roles in early-to-late breast cancer progression
15    17    1
Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker

Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
21    8    1
Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients

Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
10    11    1
Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients

Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients
12    1    1
Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): Protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score

Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): Protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
13    1    1
Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infltration in lung adenocarcinoma

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infltration in lung adenocarcinoma
21    1    1
Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy

Pan-cancer analysis identifies SPEN mutation as a predictive biomarker with the efficacy of immunotherapy
14    1    1